TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $36,000 | -47.8% | 26,668 | -56.5% | 0.00% | -100.0% |
| Q4 2018 | $69,000 | +115.6% | 61,297 | +486.5% | 0.00% | – |
| Q1 2018 | $32,000 | -55.6% | 10,451 | -8.2% | 0.00% | -100.0% |
| Q4 2017 | $72,000 | -32.7% | 11,379 | -27.1% | 0.00% | 0.0% |
| Q3 2017 | $107,000 | +5.9% | 15,608 | -40.9% | 0.00% | 0.0% |
| Q3 2016 | $101,000 | -47.7% | 26,393 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $193,000 | -49.6% | 25,863 | +147.6% | 0.00% | -50.0% |
| Q1 2015 | $383,000 | +32.5% | 10,447 | +43.7% | 0.00% | +100.0% |
| Q4 2014 | $289,000 | – | 7,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 300,000 | $1,209,000 | 0.23% |
| Rock Springs Capital Management LP | 698,000 | $2,813,000 | 0.19% |
| Eventide Asset Management | 600,000 | $2,418,000 | 0.16% |
| Teza Capital Management LLC | 14,369 | $58,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,507,000 | 0.04% |
| R&F Capital Advisors LP | 23,778 | $96,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $775,000 | 0.03% |
| Sunbelt Securities, Inc. | 6,000 | $24,180,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.03% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,654,100 | $6,666,000 | 0.02% |